Published in Mol Cell Biol on April 01, 2000
Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell (2015) 4.16
p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl). J Exp Med (2001) 1.73
Essential function for SAP family adaptors in the surveillance of hematopoietic cells by natural killer cells. Nat Immunol (2009) 1.55
Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation. J Cell Biol (2001) 1.52
Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction. Mol Cell Biol (2001) 1.48
Association of Csk to VE-cadherin and inhibition of cell proliferation. EMBO J (2005) 1.45
Nck adapter proteins: functional versatility in T cells. Cell Commun Signal (2009) 1.32
Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia. J Exp Med (2004) 1.31
Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy. Immunity (2011) 1.27
Inhibitor and activator: dual functions for SHIP in immunity and cancer. Ann N Y Acad Sci (2010) 1.25
Role of Dok-1 and Dok-2 in leukemia suppression. J Exp Med (2004) 1.23
Dok-R plays a pivotal role in angiopoietin-1-dependent cell migration through recruitment and activation of Pak. EMBO J (2001) 1.23
T cell receptor for antigen induces linker for activation of T cell-dependent activation of a negative signaling complex involving Dok-2, SHIP-1, and Grb-2. J Exp Med (2006) 1.22
A regulatory role for Src homology 2 domain-containing inositol 5'-phosphatase (SHIP) in phagocytosis mediated by Fc gamma receptors and complement receptor 3 (alpha(M)beta(2); CD11b/CD18). J Exp Med (2001) 1.20
Phosphoinositide 3-kinase-dependent membrane recruitment of p62(dok) is essential for its negative effect on mitogen-activated protein (MAP) kinase activation. J Exp Med (2001) 1.19
Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells. J Immunol (2009) 1.13
The ubiquitously expressed Csk adaptor protein Cbp is dispensable for embryogenesis and T-cell development and function. Mol Cell Biol (2005) 1.11
IkappaB kinase beta phosphorylates Dok1 serines in response to TNF, IL-1, or gamma radiation. Proc Natl Acad Sci U S A (2004) 1.11
p56(dok-2) as a cytokine-inducible inhibitor of cell proliferation and signal transduction. EMBO J (2000) 1.07
Dok-1 independently attenuates Ras/mitogen-activated protein kinase and Src/c-myc pathways to inhibit platelet-derived growth factor-induced mitogenesis. Mol Cell Biol (2006) 1.05
Downstream of tyrosine kinase 1 and 2 play opposing roles in CD200 receptor signaling. J Immunol (2010) 1.04
Distinct recruitment and function of Gab1 and Gab2 in Met receptor-mediated epithelial morphogenesis. Mol Biol Cell (2002) 1.04
Adapters in the organization of mast cell signaling. Immunol Rev (2009) 1.03
Dok-R mediates attenuation of epidermal growth factor-dependent mitogen-activated protein kinase and Akt activation through processive recruitment of c-Src and Csk. Mol Cell Biol (2005) 1.02
Cbp deficiency alters Csk localization in lipid rafts but does not affect T-cell development. Mol Cell Biol (2005) 1.02
Subcellular localization of Grb2 by the adaptor protein Dok-3 restricts the intensity of Ca2+ signaling in B cells. EMBO J (2007) 1.00
A unique autophosphorylation site on Tie2/Tek mediates Dok-R phosphotyrosine binding domain binding and function. Mol Cell Biol (2003) 1.00
Inhibition of the motility and growth of B16F10 mouse melanoma cells by dominant negative mutants of Dok-1. Mol Cell Biol (2001) 0.99
Inhibition of the Jun N-terminal protein kinase pathway by SHIP-1, a lipid phosphatase that interacts with the adaptor molecule Dok-3. Mol Cell Biol (2004) 0.92
SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF. Mol Cell Biol (2001) 0.92
Growth-factor receptor-bound protein-2 (Grb2) signaling in B cells controls lymphoid follicle organization and germinal center reaction. Proc Natl Acad Sci U S A (2011) 0.90
Functional cooperation between c-Cbl and Src-like adaptor protein 2 in the negative regulation of T-cell receptor signaling. Mol Cell Biol (2002) 0.88
Dok-related protein negatively regulates T cell development via its RasGTPase-activating protein and Nck docking sites. J Cell Biol (2002) 0.88
Oncogenic tyrosine kinases target Dok-1 for ubiquitin-mediated proteasomal degradation to promote cell transformation. Mol Cell Biol (2011) 0.87
A nuclear export signal and phosphorylation regulate Dok1 subcellular localization and functions. Mol Cell Biol (2006) 0.86
A physical interaction between the adaptor proteins DOK3 and DAP12 is required to inhibit lipopolysaccharide signaling in macrophages. Sci Signal (2013) 0.86
DOK3 negatively regulates LPS responses and endotoxin tolerance. PLoS One (2012) 0.86
Phosphoinositide lipid phosphatase SHIP1 and PTEN coordinate to regulate cell migration and adhesion. Mol Biol Cell (2012) 0.84
Hypertensive renal injury is associated with gene variation affecting immune signaling. Circ Cardiovasc Genet (2014) 0.80
Molecular control of PtdIns(3,4,5)P3 signaling in neutrophils. EMBO Rep (2015) 0.79
Dok-4 is a novel negative regulator of T cell activation. J Immunol (2009) 0.79
Inputs and outputs of insulin receptor. Protein Cell (2014) 0.78
mRNA expression of DOK1-6 in human breast cancer. World J Clin Oncol (2014) 0.77
The Dok-3/Grb2 protein signal module attenuates Lyn kinase-dependent activation of Syk kinase in B cell antigen receptor microclusters. J Biol Chem (2012) 0.77
Proteomic analysis of the SH2 domain-containing leukocyte protein of 76 kDa (SLP76) interactome in resting and activated primary mast cells [corrected]. Mol Cell Proteomics (2013) 0.77
LynA regulates an inflammation-sensitive signaling checkpoint in macrophages. Elife (2015) 0.76
Dok-2 adaptor protein regulates the shear-dependent adhesive function of platelet integrin αIIbβ3 in mice. J Biol Chem (2014) 0.76
Signal transduction by lymphocyte antigen receptors. Cell (1994) 10.63
The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck. Cell (1988) 10.47
Signaling through scaffold, anchoring, and adaptor proteins. Science (1997) 9.48
Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases. Nature (1990) 5.57
Fc receptor biology. Annu Rev Immunol (1997) 5.08
Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src. Nature (1991) 3.97
The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu Rev Immunol (1994) 3.35
Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB. Nature (1996) 3.29
Uncoupling of nonreceptor tyrosine kinases from PLC-gamma1 in an SLP-76-deficient T cell. Science (1998) 2.93
Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling. Cell (1997) 2.77
p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. Genes Dev (1996) 2.77
The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase. Proc Natl Acad Sci U S A (1996) 2.68
BLNK: a central linker protein in B cell activation. Immunity (1998) 2.59
Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok. Cell (1997) 2.44
Antigen and Fc receptor signaling. The awesome power of the immunoreceptor tyrosine-based activation motif (ITAM). J Immunol (1995) 2.40
SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity (1998) 2.39
Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells. EMBO J (1996) 2.37
p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell (1997) 2.33
SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival. Genes Dev (1999) 2.31
Analysis of the binding of the Src homology 2 domain of Csk to tyrosine-phosphorylated proteins in the suppression and mitotic activation of c-Src. Proc Natl Acad Sci U S A (1994) 2.24
Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck. Nature (1991) 2.15
BLNK required for coupling Syk to PLC gamma 2 and Rac1-JNK in B cells. Immunity (1999) 2.11
Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins in neuronal cells. EMBO J (1997) 2.09
Pleckstrin homology domains: a common fold with diverse functions. Annu Rev Biophys Biomol Struct (1998) 2.06
Negative regulation of T-cell receptor signalling by tyrosine protein kinase p50csk. Nature (1993) 2.05
Functional analysis of LAT in TCR-mediated signaling pathways using a LAT-deficient Jurkat cell line. Int Immunol (1999) 2.00
The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. Proc Natl Acad Sci U S A (1998) 1.98
The inositol polyphosphate 5-phosphatase ship is a crucial negative regulator of B cell antigen receptor signaling. J Exp Med (1998) 1.88
The Syk family of protein tyrosine kinases in T-cell activation and development. Immunol Rev (1998) 1.81
Adaptors and molecular scaffolds in immune cell signaling. Cell (1999) 1.78
Fc receptors. Curr Opin Immunol (1997) 1.74
Differential regulation of T cell antigen responsiveness by isoforms of the src-related tyrosine protein kinase p59fyn. J Exp Med (1992) 1.62
The Tek/Tie2 receptor signals through a novel Dok-related docking protein, Dok-R. Oncogene (1998) 1.57
Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins. J Biol Chem (1998) 1.48
Inhibitory pathways triggered by ITIM-containing receptors. Adv Immunol (1999) 1.44
Inhibitory receptors, ITIM sequences and phosphatases. Curr Opin Immunol (1997) 1.41
The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells. J Biol Chem (1998) 1.39
Regulation of antigen receptor signal transduction by protein tyrosine kinases. Curr Opin Immunol (1996) 1.38
Inhibitory tyrosine protein kinase p50csk is associated with protein-tyrosine phosphatase PTP-PEST in hemopoietic and non-hemopoietic cells. J Biol Chem (1997) 1.34
Association of tyrosine protein kinase Zap-70 with the protooncogene product p120c-cbl in T lymphocytes. J Exp Med (1996) 1.32
FRIP, a hematopoietic cell-specific rasGAP-interacting protein phosphorylated in response to cytokine stimulation. Immunity (1998) 1.31
Tyrosine phosphorylation of p62(Dok) induced by cell adhesion and insulin: possible role in cell migration. EMBO J (1999) 1.31
Of ITAMs and ITIMs: turning on and off the B cell antigen receptor. J Exp Med (1995) 1.27
Negative signaling in B lymphocytes induces tyrosine phosphorylation of the 145-kDa inositol polyphosphate 5-phosphatase, SHIP. J Immunol (1996) 1.26
The nonreceptor protein-tyrosine kinase CSK complexes directly with the GTPase-activating protein-associated p62 protein in cells expressing v-Src or activated c-Src. Mol Cell Biol (1995) 1.26
Role of the inositol phosphatase SHIP in B cell receptor-induced Ca2+ oscillatory response. J Immunol (1998) 1.24
Antigen receptor signaling: integration of protein tyrosine kinase functions. Oncogene (1998) 1.24
Regulation of mouse PECAM-1 tyrosine phosphorylation by the Src and Csk families of protein-tyrosine kinases. J Biol Chem (1998) 1.21
Independent SH2-binding sites mediate interaction of Dok-related protein with RasGTPase-activating protein and Nck. J Biol Chem (1999) 1.19
The Src and Csk families of tyrosine protein kinases in hemopoietic cells. Semin Immunol (1995) 1.14
Requirement of the SH3 and SH2 domains for the inhibitory function of tyrosine protein kinase p50csk in T lymphocytes. Mol Cell Biol (1995) 1.14
A 13-amino-acid motif in the cytoplasmic domain of Fc gamma RIIB modulates B-cell receptor signalling. Nature (1994) 1.12
The Syk/ZAP-70 protein tyrosine kinase connection to antigen receptor signalling processes. Semin Immunol (1995) 1.10
Interactions of the SH2 domain of lymphocyte-specific tyrosine protein kinase p56lck with phosphotyrosine-containing proteins. Oncogene (1993) 1.02
Induced direct binding of the adapter protein Nck to the GTPase-activating protein-associated protein p62 by epidermal growth factor. Oncogene (1997) 1.01
Negative regulation of antigen receptor signaling in lymphocytes. J Mol Med (Berl) (1998) 0.95
Differential effects of B cell receptor and B cell receptor-FcgammaRIIB1 engagement on docking of Csk to GTPase-activating protein (GAP)-associated p62. J Exp Med (1997) 0.95
Adaptor proteins in lymphocyte antigen-receptor signaling. Curr Opin Immunol (1998) 0.93
Negative regulation of T cell activation. Curr Opin Immunol (1998) 0.93
Inhibitory modulation of B cell receptor-mediated Ca2+ mobilization by Src homology 2 domain-containing inositol 5'-phosphatase (SHIP). J Biol Chem (1999) 0.91
The SHIP phosphatase becomes associated with Fc gammaRIIB1 and is tyrosine phosphorylated during 'negative' signaling. Immunol Lett (1996) 0.91
Immunoreceptor tyrosine-based inhibition motif-bearing receptors regulate the immunoreceptor tyrosine-based activation motif-induced activation of immune competent cells. Immunol Lett (1999) 0.91
Interactions of p62(dok) with p210(bcr-abl) and Bcr-Abl-associated proteins. J Biol Chem (1998) 0.91
Two distinct protein isoforms are encoded by ntk, a csk-related tyrosine protein kinase gene. Oncogene (1994) 0.91
A 62-kilodalton tyrosine phosphoprotein constitutively present in primary chronic phase chronic myelogenous leukemia enriched lineage negative blast populations. Leukemia (1994) 0.88
tkl is the avian homolog of the mammalian lck tyrosine protein kinase gene. Mol Cell Biol (1992) 0.86
ITAMs: immunoregulatory scaffolds that link immunoreceptors to their intracellular signaling pathways. Receptors Channels (1998) 0.86
Activation-induced bi-dentate interaction of SHIP and Shc in B lymphocytes. J Cell Biochem (1997) 0.85
Building up the family of ITIM-bearing negative coreceptors. Immunol Lett (1996) 0.84
Potential molecules implicated in downstream signaling pathways of p185BCR-ABL in Ph+ ALL involve GTPase-activating protein, phospholipase C-gamma 1, and phosphatidylinositol 3'-kinase. Leukemia (1994) 0.81
Profound block in thymocyte development in mice lacking p56lck. Nature (1992) 5.48
A database for mouse development. Science (1994) 3.96
Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med (1999) 3.48
The candidate Wilms' tumour gene is involved in genitourinary development. Nature (1990) 3.13
Building mouse phenotype ontologies. Pac Symp Biocomput (2004) 2.89
Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells. EMBO J (1996) 2.37
Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck. Nature (1991) 2.15
The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc gamma RIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity (1995) 2.12
The Syk protein tyrosine kinase is essential for Fcgamma receptor signaling in macrophages and neutrophils. Mol Cell Biol (1998) 2.10
Negative regulation of T-cell receptor signalling by tyrosine protein kinase p50csk. Nature (1993) 2.05
Herpesvirus hominis infection of the cervix associated with gonorrhoea. Lancet (1968) 1.96
Inhaled nitric oxide for persistent pulmonary hypertension of the newborn: implications and strategy for future "high-tech" neonatal clinical trials. Pediatrics (1995) 1.94
Activation of pp60c-src protein kinase activity in human colon carcinoma. Proc Natl Acad Sci U S A (1987) 1.92
Association of tyrosine kinase p56lck with CD4 inhibits the induction of growth through the alpha beta T-cell receptor. Nature (1992) 1.81
6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity. Gut (1996) 1.76
Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product. Nat Immunol (2001) 1.71
Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J Clin Invest (1995) 1.70
Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J Biol Chem (1997) 1.68
Proximal protein tyrosine kinases in immunoreceptor signaling. Curr Opin Immunol (2001) 1.67
Sequence requirements for association of protein-tyrosine phosphatase PEP with the Src homology 3 domain of inhibitory tyrosine protein kinase p50(csk). J Biol Chem (1998) 1.66
Inability of CD8 alpha' polypeptides to associate with p56lck correlates with impaired function in vitro and lack of expression in vivo. Nature (1989) 1.66
Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells. J Biol Chem (1996) 1.63
Differential regulation of T cell antigen responsiveness by isoforms of the src-related tyrosine protein kinase p59fyn. J Exp Med (1992) 1.62
Activation of p56lck through mutation of a regulatory carboxy-terminal tyrosine residue requires intact sites of autophosphorylation and myristylation. Mol Cell Biol (1990) 1.57
The management of peri-prosthetic infection in total joint arthroplasty. J Bone Joint Surg Br (2006) 1.53
Direct association of protein-tyrosine phosphatase PTP-PEST with paxillin. J Biol Chem (1998) 1.51
Retracted Systemic circulatory adjustments to acute hypoxia and reoxygenation in unanesthetized sheep. Role of renin, angiotensin II, and catecholamine interactions. J Clin Invest (1984) 1.48
Sentinel lymph node biopsy for melanoma: experience with 234 consecutive procedures. Plast Reconstr Surg (2000) 1.47
The carboxyl-terminal region of biliary glycoprotein controls its tyrosine phosphorylation and association with protein-tyrosine phosphatases SHP-1 and SHP-2 in epithelial cells. J Biol Chem (1999) 1.46
Alcohol hangover: mechanisms and mediators. Alcohol Health Res World (1998) 1.44
High expression of inhibitory receptor SHPS-1 and its association with protein-tyrosine phosphatase SHP-1 in macrophages. J Biol Chem (1998) 1.44
Defects of neuronal migration and the pathogenesis of cortical malformations are associated with Small eye (Sey) in the mouse, a point mutation at the Pax-6-locus. Acta Neuropathol (1993) 1.43
A three-dimensional model of the mouse at embryonic day 9. Dev Biol (1999) 1.42
Comparison of Gianturco Z stents and Wallstents in a hemodialysis access graft animal model. J Vasc Interv Radiol (1995) 1.42
Mutation of putative branchpoint consensus sequences in plant introns reduces splicing efficiency. Plant J (1996) 1.36
Inhibitory tyrosine protein kinase p50csk is associated with protein-tyrosine phosphatase PTP-PEST in hemopoietic and non-hemopoietic cells. J Biol Chem (1997) 1.34
Differential intrinsic enzymatic activity of Syk and Zap-70 protein-tyrosine kinases. J Biol Chem (1996) 1.33
Association of tyrosine protein kinase Zap-70 with the protooncogene product p120c-cbl in T lymphocytes. J Exp Med (1996) 1.32
Ontologies for the description of mouse phenotypes. Comp Funct Genomics (2004) 1.31
Analysis of pp60c-src in human colon carcinoma and normal human colon mucosal cells. Oncogene Res (1987) 1.29
NF-kappa B activation in tumor necrosis factor alpha-stimulated neutrophils is mediated by protein kinase Cdelta. Correlation to nuclear Ikappa Balpha. J Biol Chem (2001) 1.27
Variable expression of CD3-zeta chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function. Int J Cancer (1995) 1.25
PTP-PEST, a scaffold protein tyrosine phosphatase, negatively regulates lymphocyte activation by targeting a unique set of substrates. EMBO J (2001) 1.25
Association of biliary glycoprotein with protein tyrosine phosphatase SHP-1 in malignant colon epithelial cells. Oncogene (1997) 1.25
The affinity of hemoglobin for oxygen: its control and in vivo significance. Surgery (1970) 1.24
Oncogenic activation of p59fyn tyrosine protein kinase by mutation of its carboxyl-terminal site of tyrosine phosphorylation, tyrosine 528. J Biol Chem (1994) 1.23
An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation. J Virol (1999) 1.23
Downregulation of Lck-mediated signal transduction by tip of herpesvirus saimiri. J Virol (1995) 1.21
A new dimension for the human genome project: towards comprehensive expression maps. Nat Genet (1997) 1.21
Regulation of mouse PECAM-1 tyrosine phosphorylation by the Src and Csk families of protein-tyrosine kinases. J Biol Chem (1998) 1.21
Expression of tandem invertase genes associated with sexual and vegetative growth cycles in potato. Plant Mol Biol (1999) 1.20
Structural requirements for enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck. Mol Cell Biol (1992) 1.20
Comparison of p56lck and p59fyn protein expression in thymocyte subsets, peripheral T cells, NK cells, and lymphoid cell lines. J Immunol (1995) 1.20
A real mouse for your computer. Bioessays (1992) 1.18
Computer-aided 3-D reconstruction of serially sectioned mouse embryos: its use in integrating anatomical organization. Int J Dev Biol (1997) 1.17
Quantitation of 6-thioguanine in peripheral blood leukocyte DNA in Crohn's disease patients on maintenance 6-mercaptopurine therapy. Can J Physiol Pharmacol (1996) 1.16
Do pregnancy complications contribute to neurodevelopmental disability? Lancet (1985) 1.15
The Src and Csk families of tyrosine protein kinases in hemopoietic cells. Semin Immunol (1995) 1.14
Requirement of the SH3 and SH2 domains for the inhibitory function of tyrosine protein kinase p50csk in T lymphocytes. Mol Cell Biol (1995) 1.14
Src-related protein tyrosine kinases and T-cell receptor signalling. Trends Genet (1992) 1.13
Regulation of T-cell antigen receptor signalling by Syk tyrosine protein kinase. Mol Cell Biol (1997) 1.12
The lymphocyte-specific tyrosine protein kinase p56lck. Semin Immunol (1991) 1.12
Mood, sexuality, hormones, and the menstrual cycle. II. Hormone levels and their relationship to the premenstrual syndrome. Psychosom Med (1983) 1.12
Hormones, mood and sexuality in lactating women. Br J Psychiatry (1986) 1.12
The mechanism of feather pattern development in the chick. 1. The time of determination of feather position. J Embryol Exp Morphol (1983) 1.11
Hospital discharge. Smooth passage. Health Serv J (1999) 1.10
Modification of penicillin distribution and elimination by probenecid. Int Z Klin Pharmakol Ther Toxikol (1970) 1.10
The herpes simplex virus thymidine kinase gene promoter contains a novel thyroid hormone response element. Mol Endocrinol (1993) 1.08
The Edinburgh Mouse Atlas: using the CD. Brief Bioinform (2001) 1.07
Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBV-associated lymphoproliferative diseases. Leukemia (2012) 1.07
17 beta-estradiol regulates and v-Ha-ras transfection constitutively enhances MCF7 breast cancer cell interactions with basement membrane. Proc Natl Acad Sci U S A (1986) 1.07
Genetic evidence for a tyrosine kinase cascade preceding the mitogen-activated protein kinase cascade in vertebrate G protein signaling. J Biol Chem (1997) 1.07
Visual scanpaths in schizophrenia: is there a deficit in face recognition? Schizophr Res (1999) 1.05
Changes in mitotic indices in roots of Vicia faba. I. Antagonistic effect of colchicine and IAA. Chromosoma (1966) 1.04
Overproduction of polyomavirus middle T antigen in mammalian cells through the use of an adenovirus vector. J Virol (1987) 1.04
Coadministration of colesevelam hydrochloride with atorvastatin lowers LDL cholesterol additively. Atherosclerosis (2001) 1.04
Olanzapine reduces urge to drink after drinking cues and a priming dose of alcohol. Psychopharmacology (Berl) (2001) 1.04
The SH2 domain is required for stable phosphorylation of p56lck at tyrosine 505, the negative regulatory site. Mol Cell Biol (1993) 1.03
Interactions of the SH2 domain of lymphocyte-specific tyrosine protein kinase p56lck with phosphotyrosine-containing proteins. Oncogene (1993) 1.02
FDG-PET sensitivity for melanoma lymph node metastases is dependent on tumor volume. J Surg Oncol (2001) 1.02
Complementary tissue-specific expression of LIF and LIF-receptor mRNAs in early mouse embryogenesis. Mech Dev (1996) 1.01
Identification of Rlk, a novel protein tyrosine kinase with predominant expression in the T cell lineage. J Biol Chem (1995) 1.01
A unique insert in the linker domain of Syk is necessary for its function in immunoreceptor signalling. EMBO J (1998) 1.01
The spinal manifestations of Stickler's syndrome. Spine (Phila Pa 1976) (1999) 1.01
Zinc is essential for binding of p56(lck) to CD4 and CD8alpha. J Biol Chem (1998) 1.01
Blunting of neuroendocrine responses to infusion of L-tryptophan in women with perimenstrual mood change. Psychol Med (1991) 1.00
Cortico-spinal inhibition reflects time but not event preparation: neural mechanisms of preparation dissociated by transcranial magnetic stimulation. Acta Psychol (Amst) (1999) 1.00
Evidence from thymidine-3H-labeled meristems of Vicia faba of two cell populations. J Cell Biol (1968) 1.00
Effects of ciprofloxacin and protamine sulfate combinations against catheter-associated Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother (1995) 0.99
Proto-oncoprotein Vav interacts with c-Cbl in activated thymocytes and peripheral T cells. J Immunol (1997) 0.99
Practical application of computer-assisted decision-making in an antenatal clinic--a feasibility study. Methods Inf Med (1976) 0.99
A function for the lck proto-oncogene. Trends Biochem Sci (1989) 0.99
Regulation of SOCS-1 expression by translational repression. J Biol Chem (2000) 0.98
Clnk, a novel SLP-76-related adaptor molecule expressed in cytokine-stimulated hemopoietic cells. J Exp Med (1999) 0.98
Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy. J Clin Oncol (1999) 0.98